Subscribe Us

header ads

Recents

header ads

Artificial Intelligence (AI) in Biotechnology Market Size, Share, Forecast 2032

The global artificial intelligence (AI) in biotechnology market is surging with an overall revenue growth expectation of hundreds of millions of dollars from 2023 to 2032. North America dominated the global market in 2022.

Artificial Intelligence (AI) in Biotechnology Market Size 2023 To 2032

The on artificial intelligence (AI) in biotechnology Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2611

A recent report provides crucial insights along with application based and forecast information in the Global Artificial intelligence (AI) in biotechnology Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Artificial intelligence (AI) in biotechnology market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Artificial intelligence (AI) in biotechnology market are included as given below:

Artificial intelligence (AI) in biotechnology Market Key Players

  • AstraZeneca
  • Bristol-Myers Squibb
  • Gilead Sciences, Inc. 
  • Sanofi
  • Abbott Laboratories
  • Biogen
  • Pfizer, Inc.
  • Novo Nordisk A/S
  • Amgen, Inc.
  • Merck KGaA
  • Johnson & Johnson Services, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG

Market Segments

By Offering

  • Software
  • Hardware
  • Services

By Applications

  • Drug Target Identification
  • Drug Screening
  • Image Screening
  • Predictive Modeling

By Usage

  • Agriculture Biotechnology
  • Medical Biotechnology
  • Animal Biotechnology
  • Industrial Biotechnology

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Report Objectives

  • To define, describe, and forecast the global artificial intelligence (AI) in biotechnology market based on product, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the artificial intelligence (AI) in biotechnology market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Artificial Intelligence (AI) in Biotechnology Market 

5.1. COVID-19 Landscape: Artificial Intelligence (AI) in Biotechnology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Artificial Intelligence (AI) in Biotechnology Market, By Offering

8.1. Artificial Intelligence (AI) in Biotechnology Market, by Offering, 2023-2032

8.1.1 Software

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Hardware

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Services

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Artificial Intelligence (AI) in Biotechnology Market, By Applications

9.1. Artificial Intelligence (AI) in Biotechnology Market, by Applications, 2023-2032

9.1.1. Drug Target Identification

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Drug Screening

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Image Screening

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Predictive Modeling

9.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Artificial Intelligence (AI) in Biotechnology Market, By Usage 

10.1. Artificial Intelligence (AI) in Biotechnology Market, by Usage, 2023-2032

10.1.1. Agriculture Biotechnology

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Medical Biotechnology

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Animal Biotechnology

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Industrial Biotechnology

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Artificial Intelligence (AI) in Biotechnology Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Offering (2020-2032)

11.1.2. Market Revenue and Forecast, by Applications (2020-2032)

11.1.3. Market Revenue and Forecast, by Usage (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Offering (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Applications (2020-2032)

11.1.4.3. Market Revenue and Forecast, by Usage (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Offering (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Applications (2020-2032)

11.1.5.3. Market Revenue and Forecast, by Usage (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Offering (2020-2032)

11.2.2. Market Revenue and Forecast, by Applications (2020-2032)

11.2.3. Market Revenue and Forecast, by Usage (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Offering (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Applications (2020-2032)

11.2.4.3. Market Revenue and Forecast, by Usage (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Offering (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Applications (2020-2032)

11.2.5.3. Market Revenue and Forecast, by Usage (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Offering (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Applications (2020-2032)

11.2.6.3. Market Revenue and Forecast, by Usage (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Offering (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Applications (2020-2032)

11.2.7.3. Market Revenue and Forecast, by Usage (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Offering (2020-2032)

11.3.2. Market Revenue and Forecast, by Applications (2020-2032)

11.3.3. Market Revenue and Forecast, by Usage (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Offering (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Applications (2020-2032)

11.3.4.3. Market Revenue and Forecast, by Usage (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Offering (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Applications (2020-2032)

11.3.5.3. Market Revenue and Forecast, by Usage (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Offering (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Applications (2020-2032)

11.3.6.3. Market Revenue and Forecast, by Usage (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Offering (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Applications (2020-2032)

11.3.7.3. Market Revenue and Forecast, by Usage (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Offering (2020-2032)

11.4.2. Market Revenue and Forecast, by Applications (2020-2032)

11.4.3. Market Revenue and Forecast, by Usage (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Offering (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Applications (2020-2032)

11.4.4.3. Market Revenue and Forecast, by Usage (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Offering (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Applications (2020-2032)

11.4.5.3. Market Revenue and Forecast, by Usage (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Offering (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Applications (2020-2032)

11.4.6.3. Market Revenue and Forecast, by Usage (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Offering (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Applications (2020-2032)

11.4.7.3. Market Revenue and Forecast, by Usage (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Offering (2020-2032)

11.5.2. Market Revenue and Forecast, by Applications (2020-2032)

11.5.3. Market Revenue and Forecast, by Usage (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Offering (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Applications (2020-2032)

11.5.4.3. Market Revenue and Forecast, by Usage (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Offering (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Applications (2020-2032)

11.5.5.3. Market Revenue and Forecast, by Usage (2020-2032)

Chapter 12. Company Profiles

12.1. AstraZeneca

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Bristol-Myers Squibb

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Gilead Sciences, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Sanofi

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Abbott Laboratories

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Biogen

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Pfizer, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Novo Nordisk A/S

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Amgen, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Merck KGaA

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Post a Comment

0 Comments